ATP-dependent Proteolytic System Research Articles

Folding-Degradation Relationship of a Membrane Protein Mediated by the Universally Conserved ATP-Dependent Protease FtsH.

ATP-dependent protein degradation mediated by AAA+ proteases is one of the major cellular pathways for protein quality control and regulation of functional networks. While a majority of studies of protein degradation have focused on water-soluble proteins, it is not well understood how membrane proteins with abnormal conformation are selectively degraded. The knowledge gap stems from the lack of an in vitro system in which detailed molecular mechanisms can be studied as well as difficulties in studying membrane protein folding in lipid bilayers. To quantitatively define the folding-degradation relationship of membrane proteins, we reconstituted the degradation using the conserved membrane-integrated AAA+ protease FtsH as a model degradation machine and the stable helical-bundle membrane protein GlpG as a model substrate in the lipid bilayer environment. We demonstrate that FtsH possesses a substantial ability to actively unfold GlpG, and the degradation significantly depends on the stability and hydrophobicity near the degradation marker. We find that FtsH hydrolyzes 380-550 ATP molecules to degrade one copy of GlpG. Remarkably, FtsH overcomes the dual-energetic burden of substrate unfolding and membrane dislocation with the ATP cost comparable to that for water-soluble substrates by robust ClpAP/XP proteases. The physical principles elucidated in this study provide general insights into membrane protein degradation mediated by ATP-dependent proteolytic systems.

Reprint of “A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes”

Ubiquitin Proteasome System (UPS) is an adaptable and finely tuned system that sustains proteostasis network under a large variety of physiopathological conditions. Its dysregulation is often associated with the onset and progression of human diseases; hence, UPS modulation has emerged as a promising new avenue for the development of treatments of several relevant pathologies, such as cancer and neurodegeneration. The clinical interest in proteasome inhibition has considerably increased after the FDA approval in 2003 of bortezomib for relapsed/refractory multiple myeloma, which is now used in the front-line setting. Thereafter, two other proteasome inhibitors (carfilzomib and ixazomib), designed to overcome resistance to bortezomib, have been approved for treatment-experienced patients, and a variety of novel inhibitors are currently under preclinical and clinical investigation not only for haematological malignancies but also for solid tumours. However, since UPS collapse leads to toxic misfolded proteins accumulation, proteasome is attracting even more interest as a target for the care of neurodegenerative diseases, which are sustained by UPS impairment. Thus, conceptually, proteasome activation represents an innovative and largely unexplored target for drug development. According to a multidisciplinary approach, spanning from chemistry, biochemistry, molecular biology to pharmacology, this review will summarize the most recent available literature regarding different aspects of proteasome biology, focusing on structure, function and regulation of proteasome in physiological and pathological processes, mostly cancer and neurodegenerative diseases, connecting biochemical features and clinical studies of proteasome targeting drugs.

Tracing the history of the ubiquitin proteolytic system: The pioneering article

A series of findings made by several researchers during a two-decade period between the mid-1950s and mid-1970s raised the suspicion that the lysosome might not be the organelle that degrades the bulk of cellular proteins under basal conditions. These findings predicted the existence of a nonlysosomal, adenosine triphosphate (ATP)-dependent proteolytic system. Yet, following the initial discovery of such activity in a crude cell extract, it was a single article published in this journal [A. Ciechanover, Y. Hod, A. Hershko, A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes, Biochem. Biophys. Res. Commun. 81 (1978) 1100–1105], my first study as a graduate student of Avram Hershko, that made it clear that the system that catalyzes the activity is novel and complex, and does not follow the paradigm in the field of proteolysis where a single protease typically cleaves its substrate; here at least two components were required to carry out this activity, and one of them was an unusual, small, and heat-stable protein later identified as ubiquitin.

Turnover of Mitochondrial Steroidogenic Acute Regulatory (StAR) Protein by Lon Protease: The Unexpected Effect of Proteasome Inhibitors

Steroidogenic acute regulatory protein (StAR) is a vital mitochondrial protein promoting transfer of cholesterol into steroid making mitochondria in specialized cells of the adrenal cortex and gonads. Our previous work has demonstrated that StAR is rapidly degraded upon import into the mitochondrial matrix. To identify the protease(s) responsible for this rapid turnover, murine StAR was expressed in wild-type Escherichia coli or in mutant strains lacking one of the four ATP-dependent proteolytic systems, three of which are conserved in mammalian mitochondria-ClpP, FtsH, and Lon. StAR was rapidly degraded in wild-type bacteria and stabilized only in lon (-)mutants; in such cells, StAR turnover was fully restored upon coexpression of human mitochondrial Lon. In mammalian cells, the rate of StAR turnover was proportional to the cell content of Lon protease after expression of a Lon-targeted small interfering RNA, or overexpression of the protein. In vitro assays using purified proteins showed that Lon-mediated degradation of StAR was ATP-dependent and blocked by the proteasome inhibitors MG132 (IC(50) = 20 microm) and clasto-lactacystin beta-lactone (cLbetaL, IC(50) = 3 microm); by contrast, epoxomicin, representing a different class of proteasome inhibitors, had no effect. Such inhibition is consistent with results in cultured rat ovarian granulosa cells demonstrating that degradation of StAR in the mitochondrial matrix is blocked by MG132 and cLbetaL but not by epoxomicin. Both inhibitors also blocked Lon-mediated cleavage of the model substrate fluorescein isothiocyanate-casein. Taken together, our former studies and the present results suggest that Lon is the primary ATP-dependent protease responsible for StAR turnover in mitochondria of steroidogenic cells.

A Soluble ATP‐Dependent Proteolytic System Is Responsible for Protein Degradation

Nutrition in Clinical PracticeVolume 21, Issue 1 p. 88-91 Pivotal Paper A Soluble ATP-Dependent Proteolytic System Is Responsible for Protein Degradation Gary P. Zaloga MD, Corresponding Author gzaloga@clarian.org Methodist Research Institute, Clarian Health Partners and Department of Medicine, Indiana University School of Medicine, Indianapolis, IndianaCorrespondence: Gary Zaloga, MD, Medical Director, Methodist Research Institute, 1812 N. Capitol Ave, Wile Hall, Room 120, Indianapolis, IN 26202. Electronic mail may be sent to gzaloga@clarian.org.Search for more papers by this authorRafat Siddiqui PhD, Methodist Research Institute, Clarian Health Partners and Department of Medicine, Indiana University School of Medicine, Indianapolis, IndianaSearch for more papers by this author Gary P. Zaloga MD, Corresponding Author gzaloga@clarian.org Methodist Research Institute, Clarian Health Partners and Department of Medicine, Indiana University School of Medicine, Indianapolis, IndianaCorrespondence: Gary Zaloga, MD, Medical Director, Methodist Research Institute, 1812 N. Capitol Ave, Wile Hall, Room 120, Indianapolis, IN 26202. Electronic mail may be sent to gzaloga@clarian.org.Search for more papers by this authorRafat Siddiqui PhD, Methodist Research Institute, Clarian Health Partners and Department of Medicine, Indiana University School of Medicine, Indianapolis, IndianaSearch for more papers by this author First published: 01 February 2006 https://doi.org/10.1177/011542650602100188Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Volume21, Issue1Nutrition Concerns Associated with Gastrointestinal ConditionsFebruary 2006Pages 88-91 RelatedInformation

Abnormally high expression of proteasome activator-gamma in thyroid neoplasm.

PA28-gamma is the activator of 20S proteasome, the ATP-dependent proteolytic system that plays an important role in cell cycle progression in various cell types. In this paper, we show the abnormally high expression of PA28-gamma in various thyroid neoplasms. Thyroid samples were obtained from patients with normal thyroid (4 cases) and with the following diseases: papillary adenocarcinoma (13 cases), multinodular goiter (4 cases), and anaplastic carcinoma (1 case). PA28-gamma expression was estimated by immunohistochemical staining and Western blotting. In all of the papillary adenocarcinoma samples, PA28-gamma was abnormally overexpressed, especially in cancer cells existing at the peripheral region of the cancer mass or in cancer cells invading the capsular region surrounding the cancer mass. In cancer cells of these areas, PA28-gamma was predominantly distributed in nucleus rather than in the cytoplasm of cancer cells. On the other hand, no obvious PA28-gamma expression was observed in the adjacent normal thyroid follicular cells. In multinodular goiter, the expression of PA28-gamma was relatively low compared with papillary adenocarcinoma. In anaplastic carcinoma, PA28-gamma was expressed at the highest level, especially in poorly differentiated regions such as squamous metaplasia of anaplastic cancer tissue. Therefore, the PA28-gamma expression seems to be restricted to thyroid cancer cells, especially in the region where the growth rate of cancer cells is accelerated. This result is further confirmed by the fact that C2, alpha-subunit of 20S proteasome, and proliferating cell nuclear antigen are similarly overexpressed in this region. Thus, PA28-gamma might be involved in the regulatory system for the cell cycle. Moreover, the growth of thyroid cancer cell lines was affected by the proteasome inhibitor, clasto-lactacystin beta-lactone. These results demonstrate that PA28-gamma is overexpressed in thyroid cancer, especially in its growth-accelerated cells.

ß2-Agonists and cAMP inhibit protein degradation in isolated chick (Gallus domesticus) skeletal muscle

1. The role of β2-agonist and of cAMP in chick skeletal muscle proteolytic pathways and protein synthesis was investigated using an in vitro preparation that maintains tissue glycogen stores and metabolic activity for several hours. 2. In extensor digitorum longus (EDL) muscle total proteolysis decreased by 15 to 20% in the presence of equimolar concentrations of epinephrine, clenbuterol, a selective β2-agonist, or dibutyryl-cAMP. Rates of protein synthesis were not altered by clenbuterol or dibutyryl-cAMP. 3. The decrease in the rate of total protein degradation induced by 10−5 m clenbuterol was paralleled by a 44% reduction in Ca2+-dependent proteolysis, which was prevented by 10−5 m ICI 118·551, a selective β2-antagonist. 4. No change was observed in the activity of the lysosomal, ATP-dependent, and ATP-independent proteolytic systems. Ca2+-dependent proteolytic activity was also reduced by 58% in the presence of 10−4 m dibutyryl-cAMP or isobutylmethylxanthine. 5. The data suggest that catecholamines exert an inhibitory control of Ca2+-dependent proteolysis in chick skeletal muscle, probably mediated by β2-adrenoceptors, with the participation of a cAMP-dependent pathway.

Isolation and characterization of the prokaryotic proteasome homolog HslVU (ClpQY) from Thermotoga maritima and the crystal structure of HslV

Heat-shock locus VU (HslVU) is an ATP-dependent proteolytic system and a prokaryotic homolog of the proteasome. It consists of HslV, the protease, and HslU, the ATPase and chaperone. We have cloned, sequenced and expressed both protein components from the hyperthermophile Thermotoga maritima. T. maritima HslU hydrolyzes a variety of nucleotides in a temperature-dependent manner, with the optimum lying between 75 and 80 °C. It is also nucleotide-unspecific for activation of HslV against amidolytic and caseinolytic activity. The Escherichia coli and T. maritima HslU proteins mutually stimulate HslV proteins from both sources, suggesting a conserved activation mechanism. The crystal structure of T. maritima HslV was determined and refined to 2.1-Å resolution. The structure of the dodecameric enzyme is well conserved compared to those from E. coli and Haemophilus influenzae. A comparison of known HslV structures confirms the presence of a cation-binding site, although its exact role in the proteolytic mechanism of HslV remains unclear. Amongst factors responsible for the thermostability of T. maritima HslV, extensive ionic interactions/salt-bridge networks, which occur specifically in the T. maritima enzyme in comparison to its mesophilic counterparts, seem to play an important role.

Stability in vitro of the 69K movement protein of Turnip yellow mosaic virus is regulated by the ubiquitin-mediated proteasome pathway.

Plant viruses move to adjacent cells with the use of virus-encoded cell-to-cell movement proteins. Using proteins produced by in vitro translation, we present evidence that the '69K' movement protein of Turnip yellow mosaic virus (TYMV) is recognized as a substrate for the attachment of polyubiquitin chains and for subsequent rapid and selective proteolysis by the proteasome, the ATP-dependent proteolytic system present in reticulocyte lysate. Truncation of the 69K protein suggests the existence of two degradation signals within its sequence. We propose that selective degradation of virus movement proteins may contribute to the previously reported transient nature of their accumulation during infection.

Catecholamines inhibit Ca(2+)-dependent proteolysis in rat skeletal muscle through beta(2)-adrenoceptors and cAMP.

Overall proteolysis and the activity of skeletal muscle proteolytic systems were investigated in rats 1, 2, or 4 days after adrenodemedullation. Adrenodemedullation reduced plasma epinephrine by 95% and norepinephrine by 35% but did not affect muscle norepinephrine content. In soleus and extensor digitorum longus (EDL) muscles, rates of overall proteolysis increased by 15-20% by 2 days after surgery but returned to normal levels after 4 days. The rise in rates of protein degradation was accompanied by an increased activity of Ca(2+)-dependent proteolysis in both muscles, with no significant change in the activity of lysosomal and ATP-dependent proteolytic systems. In vitro rates of Ca(2+)-dependent proteolysis in soleus and EDL from normal rats decreased by ~35% in the presence of either 10(-5) M clenbuterol, a beta(2)-adrenergic agonist, or epinephrine or norepinephrine. In the presence of dibutyryl cAMP, proteolysis was reduced by 62% in soleus and 34% in EDL. The data suggest that catecholamines secreted by the adrenal medulla exert an inhibitory control of Ca(2+)-dependent proteolysis in rat skeletal muscle, mediated by beta(2)-adrenoceptors, with the participation of a cAMP-dependent pathway.

Search for the Cellular Functions of Plant Hsp100/Clp Family Proteins

Referee: Dr. Peter Csermely, Department of Medical Chemistry, Semmeliweis Univ. School of Medicine, P.O. Box 260, H-1444 Budapest 8, HungaryHsp100/Clp family of proteins is ubiquitously distributed in living systems. Detailed work carried out in bacterial and yeast cells has shown that regulatory members of the Clp family (mainly ClpA, ClpB, and ClpC), together with the catalytic subunit (mainly ClpP), comprise an ATP-dependent two-component proteolytic system. Members of the Hsp100/Clp protein family are not only involved in the regulation of energy-dependent protein hydrolysis but also function as molecular chaperones. However, the biochemical/physiological role(s) of the Hsp100/Clp protein family in higher plants has yet to be elucidated. Recently, this protein family has been implicated in plant stress responses: the hot1 mutant of Arabidopsis thaliana, which has mutation in hsp101 gene, and is defective in tolerance to high temperature (S.-W. Hong and E. Vierling, 2000, Proc Natl Acad Sci USA, 97 (8), 4392-4397) and the transgenic Arabidopsis thaliana plants overexpressing AtHsp101 gene exhibit high temperature tolerance (C. Quietsch et al., 2000, Plant Cell, 12, 479–492). Furthermore, the Hsp101 protein is involved in the translational regulation of cellular mRNAs and one such candidate has been identified as the photosynthetic electron transport gene Ferredoxin 1 mRNA (J. Ling et al., 2000, Plant Cell, 12, 1213–1227). We present what is known about the bacterial, yeast, and plant Hsp100/Clp proteins, discuss their possible relationship, and, more importantly, examine the cellular roles that this important family of proteins plays in plants.

Search for the Cellular Functions of Plant Hsp100/Clp Family Proteins

Hsp100/Clp family of proteins is ubiquitously distributed in living systems. Detailed work carried out in bacterial and yeast cells has shown that regulatory members of the Clp family (mainly ClpA, ClpB, and ClpC), together with the catalytic subunit (mainly ClpP), comprise an ATP-dependent two-component proteolytic system. Members of the Hsp100/Clp protein family are not only involved in the regulation of energy-dependent protein hydrolysis but also function as molecular chaperones. However, the biochemical/physiological role(s) of the Hsp100/Clp protein family in higher plants has yet to be elucidated. Recently, this protein family has been implicated in plant stress responses: the hot1 mutant of Arabidopsis thaliana, which has mutation in hsp101 gene, and is defective in tolerance to high temperature (S.-W. Hong and E. Vierling, 2000, Proc Natl Acad Sci USA, 97 (8), 4392-4397) and the transgenic Arabidopsis thaliana plants overexpressing AtHsp101 gene exhibit high temperature tolerance (C. Quietsch et al., 2000, Plant Cell, 12, 479-492). Furthermore, the Hsp101 protein is involved in the translational regulation of cellular mRNAs and one such candidate has been identified as the photosynthetic electron transport gene Ferredoxin 1 mRNA (J. Ling et al., 2000, Plant Cell, 12, 1213-1227). We present what is known about the bacterial, yeast, and plant Hsp100/Clp proteins, discuss their possible relationship, and, more importantly, examine the cellular roles that this important family of proteins plays in plants.

Branched-chain amino acids inhibit proteolysis in rat skeletal muscle: mechanisms involved.

Incubation of isolated rat soleus and EDL muscles in the presence of 10 mM leucine resulted in a decreased proteolytic rate as measured by the release of tyrosine into the incubation medium. The effect of this branched-chain amino acid (BCAA) is associated with a decreased activity of the lysosomal proteases and a decreased expression of the genes of the ATP-ubiquitin-dependent proteolysis (ubiquitin and C8). Incubation of muscles in the presence of actinomycin D revealed that the effects of the amino acid can be accounted for by an inhibition of the transcription rate. The presence of leucine did not influence the gene expression of other nonlysosomal (m-calpain) and lysosomal (cathepsin B) proteolytic systems. It is concluded that the well-known effect of BCAA on muscle proteolysis is mediated, in the short term, by the inhibition of lysosomal proteolysis. In a longer period, based on the inhibition of gene transcription observed, an involvement of the ATP-dependent proteolytic system is also likely to occur.

Proteolytic Degradation of Heme-Modified Hepatic Cytochromes P450: A Role for Phosphorylation, Ubiquitination, and the 26S Proteasome?

The resident integral hepatic endoplasmic reticulum (ER) proteins, cytochromes P450 (P450s), turn overin vivowith widely varying half-lives. We and others (Correiaet al., Arch. Biochem. Biophys.297, 228, 1992; and Tierneyet al., Arch. Biochem. Biophys.293, 9, 1992) have previously shown that in intact animals, the hepatic P450s of the 3A and 2E1 subfamilies are first ubiquitinated and then proteolyzed after their drug-induced suicide inactivation. Our findings with intact rat hepatocytes and ER preparations containing native P450s and P450s inactivated via heme modification of the protein have revealed that the proteolytic degradation of heme-modified P450s requires a cytosolic ATP-dependent proteolytic system rather than lysosomal or ER proteases (Correiaet al., Arch. Biochem. Biophys.297, 228, 1992). Using purified cumene hydroperoxide-inactivated P450s (rat liver P450s 2B1 or 3A and/or a recombinant human liver P450 3A4) as models, we now document that these heme-modified enzymes are indeed ubiquitinated and then proteolyzed by the 26S proteasome, but not by its 20S proteolytic core. In addition, our studies indicate that the ubiquitination of these heme-modified P450s is preceded by their phosphorylation. It remains to be determined whether, in common with several other cellular proteins, such P450 phosphorylation is indeed required for their degradation. Nevertheless, these findings suggest that the membrane-anchored P450s are to be included in the growing class of ER proteins that undergo ubiquitin-dependent 26S proteasomal degradation.

Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1

The implantation of the Lewis lung carcinoma (a fast-growing mouse tumour that induces cachexia) to both wild-type and transgenic mice for the soluble TNF receptor type I protein (sTNF-R1) resulted in a considerable loss of carcass weight in both groups. However, while in the wild-type mice there was a loss of both fat and muscle, in the transgenic mice muscle waste was not affected to the same extent as in the wild-type group. Muscle waste in wild-type mice was accompanied by an increase in the fractional rate of protein degradation, while no changes were observed in protein synthesis. The result was a decreased rate of protein accumulation which accounted for the muscle weight loss observed as a result of the tumour burden. In contrast, transgenic mice did not have such low rates of protein accumulation after tumour implantation. The increase in protein degradation in the tumour-bearing transgenic mice was accompanied by a similar increase in protein synthesis which compensated for the loss of muscle protein by degradation. Both tumour-bearing groups showed an enhanced expression of ubiquitin and proteasome C8 subunit genes, all of them related to the activation of the ATP-dependent proteolytic system in skeletal muscle. It is suggested that TNF may, in part, be responsible for the loss of protein in skeletal muscle of tumour-bearing mice.

Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice

The implantation of the Lewis lung carcinoma (a fast-growing mouse tumour that induces cachexia) to both wild-type and gene-deficient mice for the TNF- α receptor type I protein (Tnfr1°/Tnfr1°), resulted in a considerable loss of carcass weight in both groups. However, while in the wild-type mice there was a loss of both fat and muscle, in the gene-knockout mice muscle wastage was not affected to the same extent. In both groups, tumour burden resulted in significant increases in circulating TNF- α, a cytokine which, as we have previously demonstrated, can induce protein breakdown in skeletal muscle. Muscle wastage in wild-type mice was accompanied by an increase in the fractional rate of protein degradation, while no changes were observed in protein synthesis. The result is a decreased rate of protein accumulation that accounts for the muscle weight loss observed as a result of tumour burden. In contrast, gene knockout mice did not have significantly lower rates of protein accumulation as a result of tumour implantation. The increase in protein degradation in the tumour-bearing wild mice was accompanied by an enhanced expression of both ubiquitin and proteasome subunit genes, all of them related to the activation of the ATP-dependent proteolytic system in skeletal muscle. Tumour-bearing gene-deficient mice did not show any increase in gene expression. It is concluded that TNF- α (alone or in combination with other cytokines) is responsible for the activation of protein breakdown in skeletal muscle of tumour-bearing mice.

Mechanisms and regulation of ubiquitin-mediated cyclin degradation.

We have been studying the biochemical mechanisms of intracellular protein degradation in an ATP-dependent proteolytic system from reticulocytes. Our studies led to the identification of a pathway mediated by ubiquitin (Ub), a highly conserved 76-amino acid residue polypeptide. We found that proteins are committed to degradation by their covalent ligation to Ub. We have also identified several enzymatic reactions in the formation and breakdown of Ub-protein conjugates. Currently available information on the enzymatic reactions of the Ub proteolytic pathway is reviewed in refs. 1–3 and is summarized in Fig. 1. The initial reaction is the activation of the C-terminal Gly residue of Ub by a specific enzyme, E1 (Step 1). Next, activated Ub is further transferred by transacylation to thiol groups of a family of Ub-carrier proteins, E2s (Step 2). Multiple species of E2 were observed in reticulocytes (4) and yeasts (5). Some species of E2 may transfer Ub directly to certain proteins, such as histones (Step 3). In most cases leading to protein degradation, the ligation of Ub to specific proteins requires a third enzyme, E3. The Ub-protein ligase E3 binds suitable substrates (ref. 6, Step 4) and an E2 (7), and thus allows the transfer of Ub from E2 to the protein substrate. Two species of E3, called E3αand E3ß, have been isolated from reticulocytes. E3α binds proteins with basic or hydrophobic N-terminal amino acid residues (8, 9), while E3ß mainly acts on proteins with small, uncharged amino acid residues at the N-terminal position (10). In the ligation process, isopeptide bonds are formed between the C-terminal Gly residue of Ub end ε-amino groups of Lys residues of proteins. In all cases of E3-dependent ligation and in some E3-independent reactions, multiple Ub units are linked to proteins.

Fructated Protein Is More Resistant to ATP-Dependent Proteolysis than Glucated Protein Possibly as a Result of Higher Content of Maillard Fluorophores

Glycation by fructose (fructation) renders bovine serum albumin more refractory to degradation by an ATP-dependent proteolytic system from reticulocytes than glycation by glucose (glucation), It appears that the decrease in the protein′s susceptibility to degradation is a complex effect of the various protein-bound moities that are generated at the different stages of the Maillard reaction and not only the result of primary amino group blockage, Advanced Maillard reaction fluorescent components may induce a decrease in proteolysis, whereas the intermediate Amadori groups possibly may enhance degradation. However, the inhibitory effect on degradation of the fluorophores would predominate at higher levels of glycation, Resistance of intracellular fructated proteins to ATP-dependent degradation may lead to alterations in the function of cells with an active sorbitol pathway and, in this way, underlie the complications of diabetes.

The encephalomyocarditis virus 3C protease is a substrate for the ubiquitin-mediated proteolytic system.

The encephalomyocarditis virus 3C protease has been shown to be rapidly degraded in infected cells and in vitro in rabbit reticulocyte lysate. The in vitro degradation, at least, is accomplished by a virus-independent, ATP-dependent proteolytic system. Here we identify this proteolytic system as the ubiquitin-mediated system. Incubation of the 3C protease in rabbit reticulocyte or cultured mouse cell lysate preparations, alone or in the presence of added ubiquitin or methylated ubiquitin, resulted in the generation of new higher molecular weight species. These new products were shown to be 3C protease-ubiquitin conjugates by their ability to bind antibodies against both the 3C protease and ubiquitin. Supplemental ubiquitin also stimulated the degradation of the 3C protease in these preparations. Large 3C protease-polyubiquitin conjugates were observed to accumulate in reticulocyte lysate in the presence of adenosine 5'-O-(3-thiotriphosphate), an inhibitor of the 26 S multicatalytic protease. This, combined with the fact that the proteolytic activity could be removed from the lysate by sedimentation, implicates the multicatalytic protease in the degradation of the 3C protease-ubiquitin conjugates. It was also found that the slow rate of degradation of a model polyprotein, which resembles the stable viral 3CD diprotein produced in vivo, is likely due to the fact that the polyprotein is a poor substrate for the ubiquitin-conjugating system.

Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats.

Rats bearing the fast-growing AH-130 Yoshida ascites hepatoma showed a marked cachectic response which has been previously reported [Tessitore et al. (1987) Biochem. J. 241, 153-159]. Thus tumour-bearing animals showed significant decreases in body and muscle weight (soleus and gastrocnemius) as compared to both pair-fed and ad libitum-fed animals. These decreases were related to an enhanced proteolytic rate in the muscles of the tumour-bearing animals as measured by the tyrosine released in in vitro assays. In an attempt to elucidate which proteolytic system is directly responsible for the decrease in muscle mass, we have studied both lysosomal and non-lysosomal (ATP-dependent) proteolytic systems in this animal model. While the enzymatic activities of the main cathepsin (B and B + L) systems were actually decreased in gastrocnemius muscles of tumour-bearing rats, thus indicating that lysosomal proteolysis was not involved, the ubiquitin pools (both free and conjugated) were markedly altered as a result of tumour burden. These were associated with an increased ubiquitin gene expression in muscle of tumour-bearing rats, over 500% in relation to non-tumour bearers, thus suggesting that the ATP-dependent proteolytic system may be responsible for the muscle proteolysis and wastage observed in this animal tumour model. The fact that we have previously shown that TNF enhances the ubiquitinization of muscle proteins [García-Martínez et al. (1993) FEBS Lett. 323, 211-214], together with the high circulating levels of TNF detected in rats bearing the Yoshida hepatoma allows us to suggest that the cytokine may be responsible, most probably indirectly, for the activation of the referred proteolytic system in tumour-bearing rats.